SCHEMBL5368231

SCHEMBL5368231

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc4ccccc4c3)cc2)ccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 3/20 0.53
POLB P06746 2/20 0.49
PKM P14618 1/20 0.48
PKLR P30613 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
HTT P42858 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
PABPC1 P11940 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376861 0.90 POLB (0.56) PLAUPOLBPKMPKLRSMN1; SMN2
SCHEMBL5376629 0.89 CASP6 (0.52) POLBPKMSMN1; SMN2HTTKMT2A
SCHEMBL5378678 0.88 POLB (0.50) PLAUPOLBSMN1; SMN2HTTKMT2A
SCHEMBL5380795 0.86 POLB (0.47) POLBSMN1; SMN2HTTKMT2AMEN1
SCHEMBL5373887 0.85 POLB (0.49) POLBSMN1; SMN2HTTKMT2AMEN1
SCHEMBL5382317 0.85 POLB (0.51) PLAUPOLBSMN1; SMN2HTTKMT2A
SCHEMBL5372082 0.84 PLAU (0.46) PLAUPOLBPKMPKLRSMN1; SMN2
SCHEMBL5921903 0.84 HDAC3 (0.50) POLBPKLRSMN1; SMN2HTTKMT2A
SCHEMBL5376596 0.83 POLB (0.49) POLBSMN1; SMN2HTTKMT2AMEN1
SCHEMBL5377045 0.83 SMN1; SMN2 (0.54) POLBSMN1; SMN2HTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD PLAU 3190/4885POLB 1807/4885PKM 861/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD PLAU 3215/4885POLB 2006/4885PKM 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.